This content is restricted.
Brief
"On 27/11, Anvisa's Collegiate Board approved three public consultations to revise the regulatory framework for herbal medicines. The proposals aim to replace the current regulations on registration and notification of herbal medicines (Resolution RDC 26/2014) and three related Instruções Normativas (INs)." "The consultations cover simplified registration, prohibitions, and restrictions applicable to registration and notification of herbal medicines, as well as a list of pesticide residues to be evaluated in plant species used in herbal medicine production.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested